OPKO Health Inc. (NASDAQ:OPK) is moving in range after the company announced the signing of an exclusive global contract with CAMP4 Therapeutics Corporation for manufacturer, development, and marketing therapeutics that use AntagoNAT tech. AntagoNAT technology is an oligonucleotide therapeutics platform created within OPKO CURNA targeting non-coding antisense transcripts that lead to desired functional proteins upregulation. …
Continue reading “OPKO Health Inc. (NASDAQ:OPK) Stock Continues to Trade in a Range: Now What?”